Cytek Biosciences, Inc. CTKB Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s net change in cash?
- Cytek Biosciences, Inc. (CTKB) reported net change in cash of -$25.19M in Q1 2026.
- How has Cytek Biosciences, Inc.'s net change in cash changed year-over-year?
- Cytek Biosciences, Inc.'s net change in cash decreased by 630.9% year-over-year, from -$3.45M to -$25.19M.
- What is the long-term trend for Cytek Biosciences, Inc.'s net change in cash?
- Over 2 years (2021 to 2024), Cytek Biosciences, Inc.'s net change in cash has grown at a -41.1% compound annual growth rate (CAGR), from $198.5M to -$68.89M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.